Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BarthHaas is the world's largest provider of hop-related products and services, with a significant and growing presence in the life sciences and nutraceutical sectors. The company leverages its deep expertise in hop chemistry to develop bioactive ingredients for health, nutrition, and cosmetic applications. Their portfolio includes high-purity extracts and purified compounds such as xanthohumol and 8-prenylnaringenin, which are utilized for their antioxidant, anti-inflammatory, and estrogenic properties. BarthHaas operates advanced research and development facilities focused on the isolation and characterization of secondary plant metabolites. Through its BarthHaas Innovations division, the company collaborates with pharmaceutical and supplement manufacturers to integrate hop-derived solutions into health products. Headquartered in Germany, the company maintains a global footprint with extensive manufacturing and extraction capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BarthHaas.